Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Why Iovance Biotherapeutics Stock Was Climbing Today (Fool) +++ IOVANCE Aktie -3,21%

BIOVAXYS Aktie

>BIOVAXYS Performance
1 Woche: +5,0%
1 Monat: -12,5%
3 Monate: -19,2%
6 Monate: -70,0%
1 Jahr: -78,6%
laufendes Jahr: -68,7%
>BIOVAXYS Aktie
Name:  BIOVAXYS TECHNOLOGY CORP.
Land:  Kanada
Sektor:  Gesundheit
ISIN/ Wkn:  CA09076M1014 / A2QE16
Symbol/ Ticker:  5LB (Frankfurt)
Kürzel:  FRA:5LB, ETR:5LB, 5LB:GR
Index:  -
Webseite:  https://biovaxys.com/
Profil:  Biovaxys Technology Corp. is a biotechnology compa..
>Volltext..
Marktkapitalisierung:  4.52 Mio. EUR
Unternehmenswert:  4.6 Mio. EUR
Umsatz:  -
EBITDA:  -3.03 Mio. EUR
Nettogewinn:  -3.92 Mio. EUR
Gewinn je Aktie:  -0.02 EUR
Schulden:  0.08 Mio. EUR
Liquide Mittel:  -
Operativer Cashflow:  -1.45 Mio. EUR
Bargeldquote:  -
Umsatzwachstum:  -
Gewinnwachstum:  -12.78%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  BIOVAXYS
Letzte Datenerhebung:  19.08.25
>BIOVAXYS Kennzahlen
Aktien/ Unternehmen:
Aktien: 291.53 Mio. St.
Frei handelbar: 86.51%
Leerverk. Aktien: -
Rückkaufquote: -44.76%
Mitarbeiter: -
Umsatz/Mitarb.: -
Analysten:
Analystenrating: Neutral
Kursziel: -
Bewertung:
KGV: -
KGV lG: -
KUV: -
KBV: -
PEG-Ratio: -
EV/EBITDA: -
Rentabilität:
Bruttomarge: -
Gewinnmarge: -
Operative Marge: -
Managementeffizenz:
Gesamtkaprendite: -440.76%
Eigenkaprendite: -
>BIOVAXYS Peer Group

Es sind 185 Aktien bekannt.
 
28.07.25 - 11:12
XFRA: SPAFR - HANDELSUNTERBRECHUNG IN DIVERSEN AUSLANDSAKTIEN - TEIL 5 (XETRA)
 
CA37640A4028 CA67010X1042 AU0000373722 CA29385B1094 CA83569N2077 DK0060816148 GB00BS3D4G58 JE00BRJ8YF63 SE0005731833 SE0012481570 AU000000APA1 AU0000033946 CA00654D2095 CA4315022026 CA45083C1086 GB00BDFGGK53 GB00BMTV7393 GG00BGDYDZ69 SE0016101844 SE0017885379 AU000000SPL0 AU000000WLD8 CA0813791096 CA3804732079 CA60306F1018 AU000000MFG4 AU0000296022 CA53044R8839 CA56658A4019 SE0020388932 AU000000OLI4 CA03820A1093 CA15234A4000 CA30222R1091 CA0037351073 CA15850F1053 CA31773B5018 CA41138T1057 CA72703G2027 CA98402E2069 CNE1000003R8 JP3889200006 AU000000SSM2 SE0015658570 CA30336V1031 CA3060442074 CA3194101067 CA8552811017 IT0001469995 SE0003491562 CA45250A4063 CA7759041055 SE0000396061 AU000000ACR3 CA53680T1021 CA68237A1093 CA69867J1057 FI4000233317 SE0009921588 CA09076M1014 CA38217M1005 FR0012596468 GB00BD5JRP64 AU000000EPM8 AU0000317976 CA05455X2059 NO0010081235 SE0011311554 SE0022240115 SE0023439500 AU0000372054 CA00289A1093 CA01559R4008...
16.07.25 - 00:21
BIOVAXYS ANNOUNCES EXTENSION OF OFFERING CLOSING DATE (PR Newswire)
 
// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // VANCOUVER, BC, July 15, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") announces an extension of its previously announced brokered......
07.07.25 - 22:33
BIOVAXYS ENGAGES ENCLAVE CAPITAL LLC TO ACT AS AN AGENT IN BROKERED PRIVATE PLACEMENT OFFERING (PR Newswire)
 
// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // VANCOUVER, BC, July 7, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") announces it has engaged Enclave Capital LLC ("Enclave") to......
20.06.25 - 08:24
BIOVAXYS ANNOUNCES AMENDED LIFE OFFERING (PR Newswire)
 
// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // VANCOUVER, BC, June 20, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") announces that it has amended the terms of its brokered......
04.06.25 - 00:57
BioVaxys Issues Corporate Update (PR Newswire)
 
VANCOUVER, BC, June 3, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") is pleased to provide a summary of current operating initiatives including the integration and disposition of assets acquired in February 2024 from the former IMV,......
30.05.25 - 14:03
BIOVAXYS ANNOUNCES CONSOLIDATION AND CONCURRENT BROKERED PRIVATE PLACEMENT OFFERING FOR GROSS PROCEEDS OF UP TO $3,000,000 (PR Newswire)
 
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC, May 30, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") announces a proposed consolidation of the common shares of the......
30.05.25 - 02:45
BioVaxys and Horizon Technology Finance Corp Execute Amendment to Asset Purchase Agreement ("APA") (PR Newswire)
 
The APA Formalized the February 2024 BioVaxys Acquisition of the Former IMV Inc. Assets VANCOUVER, BC, May 29, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") is pleased to announce today that the Company and Horizon Technology Finance......
10.05.25 - 22:12
Sona Nanotech teams with BioVaxys on cancer tech – ICYMI (Proactive Investors)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
10.05.25 - 04:48
Sona Nanotech teams with BioVaxys on cancer tech – ICYMI (Proactive Investors)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
09.05.25 - 11:36
Sona Nanotech and BioVaxys Partner to develop next-generation cancer therapies (Proactive Investors)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
08.05.25 - 21:24
Sona Nanotech and BioVaxys Partner to develop next-generation cancer therapies (Proactive Investors)
 
Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...
07.05.25 - 15:18
Sona Nanotech Inc.: BioVaxys and Sona Nanotech Enter Research Collaboration (Newsfile)
 
Vancouver, British Columbia, and Halifax, Nova Scotia--(Newsfile Corp. - May 7, 2025) - BioVaxys Technology Corp. (CSE: BIOV) (FSE: 5LB) (OTCQB: BVAXF) ("BioVaxys") and Sona Nanotech Inc. (CSE: SO......
23.04.25 - 18:18
BioVaxys und SpayVac-for-Wildlife erweitern Lizenzvereinbarung auf kommerzielle Aquakultur (News Aktuell)
 
BioVaxys Technology Corp.: Vancouver, Bc, und Madison, Wisconsin (ots/PRNewswire) - Antragsverfahren zur behördlichen Zulassung von SpayVac für Wildpferde und frei lebende Hirschpopulationen läuft BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ......
22.04.25 - 14:03
BioVaxys and SpayVac-for-Wildlife Expand License Agreement Into Commercial Aquaculture (PR Newswire)
 
Submission Process Underway for Regulatory Approval of SpayVac in Feral Horses and Free-Ranging Deer Populations VANCOUVER, BC and MADISON, Wis., April 22, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys") and SpayVac for Wildlife, Inc. are......
11.04.25 - 00:37
BioVaxys Technology Corp. Announces Revocation of Management Cease Trade Order and Closing of Debt Settlement Transaction (PR Newswire)
 
// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // VANCOUVER, BC, April 10, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") is pleased to announce the revocation of the management......
02.04.25 - 00:39
BioVaxys Technology Corp. Announces Debt Settlement Agreement (PR Newswire)
 
// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // VANCOUVER, BC, April 1, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") announces that it has entered into a debt settlement......
18.03.25 - 04:09
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update (PR Newswire)
 
VANCOUVER, BC, March 17, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") is providing this bi-weekly update on the status of the management cease trade order granted on March 3, 2025 (the "MCTO"), by its principal regulator,......
04.03.25 - 00:24
BioVaxys Technology Corp. Granted Management Cease Trade Order (PR Newswire)
 
VANCOUVER, BC, March 3, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") announces that, further to its news release dated February 13, 2025, its principal regulator, the British Columbia Securities Commission (the "BCSC"), has......
24.01.25 - 02:03
BIOVAXYS ANNOUNCES EXTENSION OF PRIVATE PLACEMENT CLOSING DATE (PR Newswire)
 
// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES // VANCOUVER, BC, Jan. 23, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") is pleased to announce, further to its news release of......
17.01.25 - 10:27
BioVaxys entwickelt DPX zum Träger der Wahl für mRNA-Impfstoffe - ein Markt, der bis 2030 auf 48.000.000.000 US-Dollar wachsen soll* (News Aktuell)
 
BioVaxys Technology Corp.: Vancouver, Bc (ots/PRNewswire) - BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) („BioVaxys" oder das „Unternehmen") hebt das Potenzial seiner DPX™-Plattform zur nicht-systemischen Immunbildung hervor, die inhärenten Grenzen ......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Täglich sterben wir: Täglich nämlich wird hinweggenommen ein Teil des Lebens, und auch dann, wenn wir wachsen, nimmt das Leben ab. - Seneca
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!